A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

BACKGROUND: Palliative systemic therapy is currently standard of care for patients with extensive metastatic colorectal cancer (mCRC). A biomarker predicting chemotherapy benefit which prevents toxicity from ineffective treatment is urgently needed. Therefore, a previously developed tissue‐derived m...

Descripción completa

Detalles Bibliográficos
Autores principales: Poel, Dennis, Gootjes, Elske C., Bakkerus, Lotte, Trypsteen, Wim, Dekker, Henk, van der Vliet, Hans J., van Grieken, Nicole C. T., Verhoef, Cornelis, Buffart, Tineke E., Verheul, Henk M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571833/
https://www.ncbi.nlm.nih.gov/pubmed/32864858
http://dx.doi.org/10.1002/cam4.3371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571833/
https://www.ncbi.nlm.nih.gov/pubmed/32864858
http://dx.doi.org/10.1002/cam4.3371

Ejemplares similares